We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$5.67B
AUM Growth
+$449M
Cap. Flow
+$100M
Cap. Flow %
1.77%
Top 10 Hldgs %
21.33%
Holding
617
New
29
Increased
183
Reduced
116
Closed
41

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$44.1M
2
ACGL icon
Arch Capital
ACGL
+$36.2M
3
XYL icon
Xylem
XYL
+$35.6M
4
AME icon
Ametek
AME
+$12M
5
GWW icon
W.W. Grainger
GWW
+$11.2M

Top Sells

Rank Stock Value
1
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$37.3M
2
PGR icon
Progressive
PGR
+$31.7M
3
INTU icon
Intuit
INTU
+$31.1M
4
VSXY
Victoria's Secret
VSXY
+$30.2M
5
NVDA icon
NVIDIA
NVDA
+$9.01M

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Healthcare 19.27%
3 Consumer Discretionary 10.8%
4 Industrials 9.16%
5 Financials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDAQ icon
451
Nasdaq
NDAQ
$52.6B
$349K 0.01%
7,002
+6,000
+599% +$325K
BCYC
452
Bicycle Therapeutics
BCYC
$270M
$349K 0.01%
14,000
– –
GL icon
453
Globe Life
GL
$14.3B
$349K 0.01%
3,200
– –
PKG icon
454
Packaging Corp of America
PKG
$22.4B
$343K 0.01%
+2,600
New +$347K
RCKT icon
455
Rocket Pharmaceuticals
RCKT
$372M
$335K 0.01%
16,700
– –
TTWO icon
456
Take-Two Interactive
TTWO
$45.8B
$330K 0.01%
+2,269
New +$297K
AWI icon
457
Armstrong World Industries
AWI
$7.58B
$318K 0.01%
4,400
-800
-15% -$54.5K
LGND icon
458
Ligand Pharmaceuticals
LGND
$5.85B
$312K 0.01%
4,300
– –
SWTX
459
DELISTED
SpringWorks Therapeutics
SWTX
$311K 0.01%
12,300
– –
RLAY icon
460
Relay Therapeutics
RLAY
$4.09B
$296K 0.01%
23,100
– –
SYF icon
461
Synchrony
SYF
$25.3B
$282K 0.01%
8,318
+5,786
+229% +$177K
BCRX icon
462
BioCryst Pharmaceuticals
BCRX
$2.24B
$278K ﹤0.01%
40,000
– –
PICK icon
463
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.2B
$277K ﹤0.01%
+6,850
New +$280K
ZNTL icon
464
Zentalis Pharmaceuticals
ZNTL
$331M
$276K ﹤0.01%
9,800
– –
REPL icon
465
Replimune Group
REPL
$1B
$275K ﹤0.01%
11,900
– –
OWL icon
466
Blue Owl Capital
OWL
$7.54B
$273K ﹤0.01%
23,460
– –
WELL icon
467
Welltower
WELL
$168B
$267K ﹤0.01%
3,300
+600
+22% +$46.2K
PBA icon
468
Pembina Pipeline
PBA
$28B
$262K ﹤0.01%
8,323
-5,508
-40% -$176K
BHVN icon
469
Biohaven
BHVN
$2.01B
$261K ﹤0.01%
10,900
– –
JNPR
470
DELISTED
Juniper Networks
JNPR
$259K ﹤0.01%
8,378
+3,648
+77% +$112K
RGNX icon
471
Regenxbio
RGNX
$638M
$258K ﹤0.01%
13,000
– –
RXRX icon
472
Recursion Pharmaceuticals
RXRX
$1.69B
$247K ﹤0.01%
33,500
– –
GRFS
473
Grifois
GRFS
$5.35B
$245K ﹤0.01%
27,056
– –
ADPT icon
474
Adaptive Biotechnologies
ADPT
$3.68B
$243K ﹤0.01%
35,700
– –
IOVA icon
475
Iovance Biotherapeutics
IOVA
$1.93B
$240K ﹤0.01%
34,000
– –
17 18
19
20 21

Similar funds

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Erste Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Erste Asset Management held 617 positions worth $5.67B, up 8.6% from $5.22B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Erste Asset Management's Q2 2023 filing shows 29 new, 183 increased, 116 reduced and 41 closed positions. Its largest new stake was UiPath: 660,000 shares worth $11M. The largest sale was Evoqua Water Technologies Corp. Common Stock, an estimated $37.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2023 buy was UiPath: 660,000 shares worth $11M.
  • Erste Asset Management added most to AstraZeneca in Q2 2023, an estimated $44.1M increase.
  • Erste Asset Management's biggest Q2 2023 reduction was Progressive, cutting an estimated $31.7M.
  • Erste Asset Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $37.3M.
  • Erste Asset Management's ten largest holdings make up 21% of its $5.67B portfolio in Q2 2023.
  • Erste Asset Management opened 29 new positions and closed 41 in Q2 2023.
  • Erste Asset Management's portfolio value rose 8.6% quarter-over-quarter to $5.67B.

Based on Erste Asset Management's 13F filing for Q2 2023, filed 26 Nov 2024.